HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuichi Saito Selected Research

mirabegron

9/2021Effect of oxybutynin patch versus mirabegron on nocturia-related quality of life in female overactive bladder patients: A multicenter randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuichi Saito Research Topics

Disease

4Inflammation (Inflammations)
10/2022 - 01/2020
4Spinal Cord Injuries (Spinal Cord Injury)
10/2022 - 01/2020
4Hypoxia (Hypoxemia)
10/2022 - 01/2020
3Ischemia
10/2022 - 11/2020
2Overactive Urinary Bladder (Overactive Bladder)
09/2021 - 09/2020
2Neoplasms (Cancer)
09/2014 - 01/2014
2Adenocarcinoma
06/2013 - 05/2013
1Diabetes Mellitus
12/2021
1Nocturia
09/2021
1Ataxia (Dyssynergia)
01/2021
1Neurogenic Urinary Bladder (Bladder, Neurogenic)
11/2020
1Fibrosis (Cirrhosis)
11/2020
1Lower Urinary Tract Symptoms
09/2020
1Testicular Neoplasms (Testicular Cancer)
05/2016
1Fibrosarcoma
09/2014
1Margins of Excision
09/2014
1Neoplasm Metastasis (Metastasis)
09/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2013
1Hemorrhage
04/2013
1Liver Diseases (Liver Disease)
04/2013
1Pelvic Organ Prolapse
01/2013

Drug/Important Bio-Agent (IBA)

5Messenger RNA (mRNA)IBA
10/2022 - 11/2020
4Proteins (Proteins, Gene)FDA Link
10/2022 - 11/2020
3Soluble Guanylyl CyclaseIBA
10/2022 - 01/2020
2Therapeutic UsesIBA
10/2022 - 12/2021
2Acid Sensing Ion ChannelsIBA
10/2022 - 01/2021
2N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
10/2021 - 11/2020
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 01/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2022
1AnkyrinsIBA
10/2022
14-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acidIBA
10/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022
1Antisense OligonucleotidesIBA
12/2021
1Insulin (Novolin)FDA Link
12/2021
1Liposomes (Liposome)IBA
12/2021
1Nerve Growth Factor (NGF)IBA
12/2021
1Transient Receptor Potential ChannelsIBA
10/2021
1Activating Transcription Factor 3IBA
10/2021
1TRPA1 Cation ChannelIBA
10/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2021
1CytokinesIBA
10/2021
1oxybutynin (Tavor)FDA LinkGeneric
09/2021
1mirabegronIBA
09/2021
1CollagenIBA
11/2020
1ElastinIBA
11/2020
1choreitoIBA
09/2020
1Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
01/2020
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
01/2020
1Multidrug Resistance-Associated ProteinsIBA
01/2020
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2020
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2016
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
06/2013
1Hemoglobins (Hemoglobin)IBA
04/2013

Therapy/Procedure

2Therapeutics
12/2021 - 09/2014
2Cystectomy
01/2014 - 05/2013
2Urinary Diversion (Ileal Conduit)
01/2014 - 05/2013
1Flowmeters
09/2020
1Lasers (Laser)
09/2020
1Kampo Medicine (Kampo)
09/2020
1Orchiopexy
05/2016
1Drug Therapy (Chemotherapy)
09/2014
1Blood Transfusion (Blood Transfusions)
04/2013
1Suburethral Slings (Tension-Free Vaginal Tape)
01/2013
1Suture Anchors
01/2013